Breztri Aerosphere vs Nucala
A side-by-side look at two respiratory medications advertised on TV. Informational only — not medical advice.
| US Breztri Aerosphere | US Nucala | |
|---|---|---|
| Generic name | budesonide/glycopyrrolate/formoterol | mepolizumab |
| Drug class | Inhaled Corticosteroid + LAMA + LABA | IL-5 Antagonist (Biologic) |
| Treats | COPD | Severe eosinophilic asthma, COPD, nasal polyps |
| Category | Respiratory | Respiratory |
| Manufacturer | AstraZeneca | GSK |
| Year approved | 2020 | 2015 |
| FDA warning | No boxed warning | No boxed warning |
| Est. TV ad spend | $120M | $75M |
| Common side effects | Respiratory infections, Thrush, Cough, Headache | Headache, Injection site reactions, Back pain, Fatigue |
Breztri Aerosphere
Frequently asked questions
Is Breztri Aerosphere or Nucala better?
Neither is universally "better." Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) and Nucala (mepolizumab) are both used for respiratory, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Breztri Aerosphere and Nucala?
Breztri Aerosphere is a Inhaled Corticosteroid + LAMA + LABA made by AstraZeneca, while Nucala is a IL-5 Antagonist (Biologic) made by GSK. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Breztri Aerosphere has the larger estimated TV advertising budget of the two.